MDPI and ACS Style
Estévez-Vázquez, O.; Benedé-Ubieto, R.; Guo, F.; Gómez-Santos, B.; Aspichueta, P.; Reissing, J.; Bruns, T.; Sanz-GarcÃa, C.; Sydor, S.; Bechmann, L.P.;
et al. Fat: Quality, or Quantity? What Matters Most for the Progression of Metabolic Associated Fatty Liver Disease (MAFLD). Biomedicines 2021, 9, 1289.
https://doi.org/10.3390/biomedicines9101289
AMA Style
Estévez-Vázquez O, Benedé-Ubieto R, Guo F, Gómez-Santos B, Aspichueta P, Reissing J, Bruns T, Sanz-GarcÃa C, Sydor S, Bechmann LP,
et al. Fat: Quality, or Quantity? What Matters Most for the Progression of Metabolic Associated Fatty Liver Disease (MAFLD). Biomedicines. 2021; 9(10):1289.
https://doi.org/10.3390/biomedicines9101289
Chicago/Turabian Style
Estévez-Vázquez, Olga, Raquel Benedé-Ubieto, Feifei Guo, Beatriz Gómez-Santos, Patricia Aspichueta, Johanna Reissing, Tony Bruns, Carlos Sanz-GarcÃa, Svenja Sydor, Lars P. Bechmann,
and et al. 2021. "Fat: Quality, or Quantity? What Matters Most for the Progression of Metabolic Associated Fatty Liver Disease (MAFLD)" Biomedicines 9, no. 10: 1289.
https://doi.org/10.3390/biomedicines9101289